Are Basant Agro Tech latest results good or bad?
Basant Agro Tech's latest Q2 FY26 results show a significant sequential decline in net sales by 40.01%, though year-on-year sales grew by 25.81%. While operating margins improved, profitability pressures remain, and the company faces challenges with weak return ratios and high debt levels, making its financial health uncertain.
Basant Agro Tech's latest financial results for Q2 FY26 reflect significant operational challenges, primarily driven by the seasonal nature of the fertiliser industry. The company reported net sales of ₹105.83 crores, which represents a 40.01% contraction on a sequential basis, though it shows a year-on-year growth of 25.81% compared to ₹84.12 crores in Q2 FY25. This decline is typical for fertiliser companies as demand peaks during the kharif sowing season.Operating margins improved to 6.18% from 4.94% in the previous quarter, indicating better cost management despite the revenue drop. However, the profit after tax (PAT) margin compressed to 0.93% from 1.43%, highlighting ongoing profitability pressures. The net profit for the quarter was ₹0.98 crores, which reflects a substantial decline of 61.11% quarter-on-quarter but an impressive increase of 188.24% year-on-year.
The company's operational performance continues to be hampered by structurally weak return ratios, with the latest return on equity (ROE) at 2.47% and return on capital employed (ROCE) at 6.95%, both of which are below industry standards. Additionally, elevated debt levels, indicated by a debt-to-EBITDA ratio of 3.54 times, further constrain financial flexibility.
Basant Agro Tech's cash flow situation showed improvement, with operating cash flow of ₹43.89 crores in FY25, a notable turnaround from negative cash flow in the previous fiscal year. However, the sustainability of this improvement remains uncertain given the volatility in the fertiliser sector.
Overall, the company saw an adjustment in its evaluation, reflecting the complexities of its operational environment and financial health. Investors should remain vigilant regarding the company's ability to navigate these challenges in the coming quarters.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
